Overexpression of ERRβ in breast cancer patients is correlated with improved prognosis and longer relapse-free survival, and the level of ERRβ mRNA is inversely correlated with the S-phase fraction of cells from breast cancer patients. The gene discussed is ESRRB; the disease is breast carcinoma.